肾癌 | Medical guideline

首页 泌尿外科指南  肾癌

肾癌

按发表年份

Tivozanib for Treating Advanced Renal Cell Carcinoma

 2018年发布于 National Institute for Health and Care Excellence 所属人体系统：泌尿 | 肾癌

 National Institute for Health and Care Excellence

Renal Cell Carcinoma treatment Tivozanib
指南简介 原文链接
Cabozantinib for Untreated Advanced Renal Cell Carcinoma

 2018年发布于 National Institute for Health and Care Excellence 所属人体系统：泌尿 | 肾癌

 National Institute for Health and Care Excellence

Renal Cell Carcinoma treatment Cabozantinib
指南简介 原文链接
肾癌伴静脉癌栓诊治专家共识

 2018年发布于中华泌尿外科杂志 39卷第12期 所属人体系统：泌尿 | 肾癌

 中华医学会泌尿外科学分会中国肾癌联盟

肾癌静脉癌栓共识
指南简介 原文链接
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer

 2018年发布于 Eur Urol 73卷第3期 所属人体系统：泌尿 | 肾癌

 European Association of Urology

European Association of Urology Guidelines Ipilimumab Nivolumab Renal Cell Carcinoma
指南简介 原文链接
German S3 Guideline for Renal Cell Carcinoma : Presentation and Discussion of Essential Aspects for the Radiation Oncologist

 2018年发布于 Strahlenther Onkol 194卷第1期 所属人体系统：泌尿 | 肾癌

 无

Purpose: We Aim to Introduce and Discuss the Statements and Recommendations of the German S3 Guideline on Renal Cell Cancer for Daily Practice of Radiation Oncologists Methods: This Report Comprises Indication Treatment Decision Dose Prescription and Current Literature Including Treatment of Oligometastatic Disease Results: According to Different Stages of the Disease and the Structure of the Guideline We Focus on Five Treatment Situations and Recommendations for Decision Making: (1) Neo-/adjuvant Treatment Before Or after Nephrectomy: No Indication for Radiotherapy (2) Small Renal Mass: Stereotactic Ablative Radiotherapy Is Currently Seen as Experimental Option due to Small Patient Numbers Reported in the Literature However Local Tumor Control Achieved by SBRT Appears Favourable with >90% at 2 Years (3) Oligometastasis: Radiation Treatment with Higher Local Doses Or Stereotactic Treatment Is Possible after Interdisciplinary Discussion Indications for Palliative (4) and Symptomatic Treatment (5) Are Not Different Compared to Other Tumor Entities Conclusion: Currently There Is No Evidence-based Indication for Radiation Treatment in the Primary Setting (adjuvant/neoadjuvant Or Definitive) of Renal Cell Cancer in the Future Stereotactic Radiotherapy Should Have a Stronger Role in the Treatment of Medically Inoperable Patients with Primary Renal Cell Cancer and Especially in the Setting of Oligometastasis
指南简介 原文链接
Elderly Patients with Metastatic Renal Cell Carcinoma: Position Paper from the International Society of Geriatric Oncology

 2018年发布于 Lancet Oncol 19卷第6期 所属人体系统：泌尿 | 肾癌

 International Society of Geriatric Oncology

Elderly Patients Metastatic Renal Cell Carcinoma
指南简介 原文链接
An Interdisciplinary Consensus on the Management of Bone Metastases from Renal Cell Carcinoma

 2018年发布于 Nat Rev Urol 15卷第8期 所属人体系统：泌尿 | 肾癌

 The International Kidney Cancer Coalition — an Independent Global Network of Patient Organizations with a Focus on Kidney Cancer — and the Interdisciplinary Working Group

Renal Cancer Bone Metastases Cancer Therapy Cancer Imaging
指南简介 原文链接
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma

 2018年发布于 Eur Urol 74卷第6期 所属人体系统：泌尿 | 肾癌

 European Association of Urology

Cytoreductive Nephrectomy EAU Guidelines Metastatic Renal Cell Cancer Sunitinib
指南简介 原文链接
French CcAFU Guidelines - Update 2018-2020: Management of Kidney Cancer

 2018年发布于 Prog Urol 所属人体系统：泌尿 | 肾癌

 The French Urological Association Oncology Committee

Cancer Du Rein Chirurgie Classification Kidney Cancer Surgery Targeted Therapy Thérapies Ciblées
指南简介 原文链接

人体系统

 2018年 发布于 National Institute for Health and Care Excellence 所属人体系统： 泌尿 | 肾癌

 National Institute for Health and Care Excellence

 2018年 发布于 National Institute for Health and Care Excellence 所属人体系统： 泌尿 | 肾癌

 National Institute for Health and Care Excellence

 2018年 发布于 中华泌尿外科杂志 39卷 第12期 所属人体系统： 泌尿 | 肾癌

 中华医学会泌尿外科学分会中国肾癌联盟

 2018年 发布于 Eur Urol 73卷 第3期 所属人体系统： 泌尿 | 肾癌

 European Association of Urology

 2018年 发布于 Strahlenther Onkol 194卷 第1期 所属人体系统： 泌尿 | 肾癌

 无

 2018年 发布于 Lancet Oncol 19卷 第6期 所属人体系统： 泌尿 | 肾癌

 International Society of Geriatric Oncology

 2018年 发布于 Nat Rev Urol 15卷 第8期 所属人体系统： 泌尿 | 肾癌

 The International Kidney Cancer Coalition — an Independent Global Network of Patient Organizations with a Focus on Kidney Cancer — and the Interdisciplinary Working Group

 2018年 发布于 Eur Urol 74卷 第6期 所属人体系统： 泌尿 | 肾癌

 European Association of Urology

 2018年 发布于 Prog Urol 所属人体系统： 泌尿 | 肾癌

 The French Urological Association Oncology Committee

 2018年发布于 National Institute for Health and Care Excellence 所属人体系统：泌尿 | 肾癌

 2018年发布于 National Institute for Health and Care Excellence 所属人体系统：泌尿 | 肾癌

 2018年发布于中华泌尿外科杂志 39卷第12期 所属人体系统：泌尿 | 肾癌

 2018年发布于 Eur Urol 73卷第3期 所属人体系统：泌尿 | 肾癌

 2018年发布于 Strahlenther Onkol 194卷第1期 所属人体系统：泌尿 | 肾癌

 2018年发布于 Lancet Oncol 19卷第6期 所属人体系统：泌尿 | 肾癌

 2018年发布于 Nat Rev Urol 15卷第8期 所属人体系统：泌尿 | 肾癌

 2018年发布于 Eur Urol 74卷第6期 所属人体系统：泌尿 | 肾癌

 2018年发布于 Prog Urol 所属人体系统：泌尿 | 肾癌